Azacitidine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Azacitidine and local guidelines before prescribing.

Hypomethylating agent

Mechanism

Hypomethylating nucleoside analogue.

Uses

Myelodysplastic syndromes, AML.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Myelosuppression, nausea, injection-site reactions, infection.

Interactions

Few.

Contraindications and cautions

Advanced liver tumour

Monitoring

FBC, LFT, renal function

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Caution in renal and hepatic impairment

Overdose and reversal

Supportive

Special advice

Subcutaneous cycles of 7 days; blood count before each cycle.

More from the textbook: uses, cautions and other points
Where it is discussed in the book